三元生物
(301206)
| 流通市值：30.81亿 | | | 总市值：47.85亿 |
| 流通股本：1.30亿 | | | 总股本：2.02亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 428,710,939.19 | 224,781,048.39 | 649,511,864.38 | 476,077,165.85 |
| 营业总成本 | 395,448,253.26 | 208,040,014.29 | 615,716,180.92 | 450,764,643.46 |
| 其他经营收益 | | | | |
| 营业利润 | 57,480,487.14 | 29,430,079.04 | 105,039,167.08 | 77,782,577.44 |
| 利润总额 | 57,501,270.63 | 29,448,914.6 | 105,427,089 | 77,769,156.64 |
| 净利润 | 50,397,586.8 | 26,091,444.3 | 91,296,559.96 | 67,284,664.85 |
| 每股收益 | | | | |
| 其他综合收益 | -124,469.69 | -160,103.28 | 158,013.72 | - |
| 综合收益总额 | 50,273,117.11 | 25,931,341.02 | 91,454,573.68 | 67,284,664.85 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 1,687,542,005.22 | 1,396,528,945.74 | 2,163,820,942.01 | 2,270,871,424.14 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,791,876,832.88 | 3,057,422,557.41 | 2,255,019,569.25 | 2,211,058,162.16 |
| 资产总计 | 4,479,418,838.1 | 4,453,951,503.15 | 4,418,840,511.26 | 4,481,929,586.3 |
| 流动负债: | | | | |
| 流动负债合计 | 233,386,605.66 | 132,246,105.51 | 117,985,720.31 | 107,703,968.66 |
| 非流动负债: | | | | |
| 非流动负债合计 | 55,974,211.2 | 56,646,833.68 | 61,727,568.01 | 59,268,303.53 |
| 负债合计 | 289,360,816.86 | 188,892,939.19 | 179,713,288.32 | 166,972,272.19 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 4,190,058,021.24 | 4,265,058,563.96 | 4,239,127,222.94 | 4,314,957,314.11 |
| 股东权益合计 | 4,190,058,021.24 | 4,265,058,563.96 | 4,239,127,222.94 | 4,314,957,314.11 |
| 负债和股东权益合计 | 4,479,418,838.1 | 4,453,951,503.15 | 4,418,840,511.26 | 4,481,929,586.3 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 472,501,932.45 | 230,893,391.33 | 767,673,922.87 | 590,549,351.45 |
| 经营活动现金流出小计 | 398,864,703.15 | 168,571,943.06 | 744,858,185.85 | 565,446,870.82 |
| 经营活动产生的现金流量净额 | 73,637,229.3 | 62,321,448.27 | 22,815,737.02 | 25,102,480.63 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 5,023,271,062.16 | 3,076,297,674.86 | 9,201,280,702.34 | 8,666,557,877.99 |
| 投资活动现金流出小计 | 4,735,095,821.23 | 3,204,700,433.45 | 8,666,434,003.39 | 8,301,246,433.7 |
| 投资活动产生的现金流量净额 | 288,175,240.93 | -128,402,758.59 | 534,846,698.95 | 365,311,444.29 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | 3,400,000 | 2,000,000 |
| 筹资活动现金流出小计 | - | - | 395,132,474.32 | 284,787,819.71 |
| 筹资活动产生的现金流量净额 | - | - | -391,732,474.32 | -282,787,819.71 |
| 汇率变动对现金及现金等价物的影响 | -1,371,869.18 | -1,258,762.9 | -1,286,823.88 | -754,789.21 |
| 现金及现金等价物净增加额 | 360,440,601.05 | -67,340,073.22 | 164,643,137.77 | 106,871,316 |
| 期末现金及现金等价物余额 | 685,376,091.85 | 257,595,417.58 | 324,935,490.8 | 267,163,669.03 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 360,440,601.05 | - | 164,643,137.77 | - |